Like other beta blockers, Bystolic decreases heart rate and myocardial contractility, and suppresses renin activity. Bystolic is a selective beta 1 blocker at doses less than or equal to 10 mg per day ...

The U.S. Food and Drug Administration (FDA) has approved Bystolic™ (nebivolol) for the treatment of hypertension, also known as high blood pressure. Hypertension affects approximately 72 million ...

New York, NY -A new beta blocker, nebivolol (Bystolic, Forest/Mylan), has been approved by the US FDA for the treatment of hypertension. The drug is a selective beta 1 blocker and has the added ...

Patients with hypertension (high blood pressure) have a new generic medication to treat their condition. Camber is offering nebivolol tablets. The medication is the generic of Bystolic. Camber’s ...

NEW YORK — Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension. East Brunswick, N.J.-based Amerigen Pharmaceuticals announced ...

January 7, 2010 (Washington, DC) — Available evidence doesn't justify extending approval of the beta blocker nebivolol (Bystolic, Forest Laboratories) to include treatment of chronic heart failure, ...

These statements involve a number of risks and uncertainties, including regulatory matters outside of the companies' control, the acceptance and demand for Bystolic, the impact of competitive products ...

Federal health advisers on Monday unanimously rejected a new use of Forest Laboratories' hypertension drug for patients at risk of heart failure. The Food and Drug Administration's outside panel of ...

CVS Pharmacy Inc and Rite Aid Corp have sued AbbVie Inc and several generic drugmakers over an alleged scheme to keep generic versions of AbbVie's blood pressure drug Bystolic off the market through ...